Back to Search
Start Over
In Vivo Bone-Targeting of Bis(phosphonate)-Conjugated Double Helical RNA Monitored by Positron Emission Tomography
- Source :
- Molecular Pharmaceutics. 13:2588-2595
- Publication Year :
- 2016
- Publisher :
- American Chemical Society (ACS), 2016.
-
Abstract
- A bis(phosphonate) conjugate of 2'-O-methyl oligoribonucleotide (microRNA-21) was synthesized and used as a bone-targeting carrier in the systemic delivery of a (68)Ga-1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA)-chelated 2'-O-methyl oligoribonucleotide (anti-microRNA-21). The whole-body biodistribution of the double helical RNA was monitored by positron emission tomography (PET), which verified the expected bis(phosphonate)-induced bone accumulation in healthy rats.
- Subjects :
- Male
0301 basic medicine
Biodistribution
Pharmaceutical Science
Gallium Radioisotopes
Conjugated system
Rats, Sprague-Dawley
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Heterocyclic Compounds
In vivo
Drug Discovery
medicine
Animals
RNA, Small Interfering
ta317
Chelating Agents
medicine.diagnostic_test
Chemistry
Radiochemistry
RNA
Phosphonate
Rats
3. Good health
030104 developmental biology
Bone targeting
Biochemistry
Positron emission tomography
Positron-Emission Tomography
030220 oncology & carcinogenesis
Molecular Medicine
Conjugate
Subjects
Details
- ISSN :
- 15438392 and 15438384
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Molecular Pharmaceutics
- Accession number :
- edsair.doi.dedup.....e7bdbb8a661266baa4b0c50e788c55e3
- Full Text :
- https://doi.org/10.1021/acs.molpharmaceut.6b00261